Glorium Technologies Announces Participation in DMEA 2024
Updated April 4, 2024
Glorium Technologies is excited to announce its participation in the DMEA 2024: Next Level of Digital Health event. This significant gathering, set to take place from 9 to 11 April 2024 in the Berlin exhibition halls, promises to bring together more than 700 exhibitors and over 16,000 attendees, making it Europe’s most crucial event for digital health innovation.
At DMEA 2024, our company will showcase its commitment to developing solutions that meet the healthcare industry’s unique needs. By providing a range of services, from app development to comprehensive software solutions, Our team is dedicated to enhancing healthcare services with the latest technology.
Glorium Technologies is a full-cycle app and software development company committed to addressing specific client business needs with the best technological solutions. With a focus on the healthcare sector, Glorium empowers organizations to optimize their operations and deliver superior patient care through innovative digital solutions.
Anna Vozna, an Account Executive at Glorium Technologies, will represent the company at the event. With a deep understanding of the healthcare sector’s challenges and opportunities, Ms. Vozna looks forward to sharing insights and connecting with other professionals dedicated to advancing digital health.
We are thrilled to be a part of DMEA 2024 and share our vision for a healthier future through technology. It’s an excellent opportunity for us to learn from the healthcare community and showcase how our 13+ years of expertise can support the growing needs of this vital sector.
Anna VoznaAccount Executive, Glorium Technologies
Attendees are encouraged to visit the Glorium Technologies booth to learn more about how the company’s offerings can help healthcare organizations improve efficiency, patient care, and outcomes. The team is eager to demonstrate their latest projects and discuss how they can support your digital health initiatives. For further information about our participation, please contact Anna Vozna on LinkedIn.
